November 22, 2019

NBIL has used Fusion 360 to develop India’s first commercial 3D Bioprinter (TRIVIMA)

NBIL has created India’s first commercial 3D Bioprinter, which is completely customizable. It allows 3D Bioprinting scientists to explore and address various 3D Bioprinting requirements. Its applications include development of 3D printed scaffolds for R&D, development of tissue disease models for R&D, stem cell research and development, bioprinting of tissues for in-vitro modelling among other areas of application.

►FREE TRIAL | https://autode.sk/2uLm8a6
►SUBSCRIBE | https://autode.sk/2q61ZpD
►GET STARTED | https://autode.sk/2HaB2Jk

CONNECT:
INSTAGRAM | https://autode.sk/2Enzh8P
FACEBOOK | http://autode.sk/19jII5A
TWITTER | http://autode.sk/19jIJXc

Powered by WPeMatico

linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram